| Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management AMJ Wensing, DA Van De Vijver, G Angarano, B Åsjö, C Balotta, E Boeri, ... The Journal of infectious diseases 192 (6), 958-966, 2005 | 540 | 2005 |
| European guidelines on the clinical management of HIV-1 tropism testing LPR Vandekerckhove, AMJ Wensing, R Kaiser, F Brun-Vézinet, B Clotet, ... The Lancet infectious diseases 11 (5), 394-407, 2011 | 288 | 2011 |
| Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe LM Hofstra, N Sauvageot, J Albert, I Alexiev, F Garcia, D Struck, ... Clinical infectious diseases 62 (5), 655-663, 2016 | 141 | 2016 |
| Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach D Paraskevis, O Pybus, G Magiorkinis, A Hatzakis, AMJ Wensing, ... Retrovirology 6 (1), 1-11, 2009 | 139 | 2009 |
| The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes DA van de Vijver, AMJ Wensing, G Angarano, B Åsjö, C Balotta, E Boeri, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 41 (3), 352-360, 2006 | 133 | 2006 |
| Beyond sparsity: Tree regularization of deep models for interpretability M Wu, M Hughes, S Parbhoo, M Zazzi, V Roth, F Doshi-Velez Proceedings of the AAAI Conference on Artificial Intelligence 32 (1), 2018 | 129 | 2018 |
| Antiretroviral resistance mutations in human immunodeficiency virus type 1 reverse transcriptase and protease from paired cerebrospinal fluid and plasma samples G Venturi, M Catucci, L Romano, P Corsi, F Leoncini, PE Valensin, ... The Journal of infectious diseases 181 (2), 740-745, 2000 | 123 | 2000 |
| A novel methodology for large-scale phylogeny partition MCF Prosperi, M Ciccozzi, I Fanti, F Saladini, M Pecorari, V Borghi, ... Nature communications 2 (1), 1-10, 2011 | 112 | 2011 |
| The development of artificial neural networks to predict virological response to combination HIV therapy B Larder, D Wang, A Revell, J Montaner, R Harrigan, F De Wolf, J Lange, ... Antiviral therapy 12 (1), 15, 2007 | 95 | 2007 |
| Evaluation of the Abbott Real-Time HIV-1 quantitative assay with dried blood spot specimens A Marconi, M Balestrieri, G Comastri, FR Pulvirenti, W Gennari, ... Clinical microbiology and infection 15 (1), 93-97, 2009 | 88 | 2009 |
| Clinically validated genotype analysis: guiding principles and statistical concerns. F Brun-Vezinet, D Costagliola, MA Khaled, V Calvez, F Clavel, B Clotet, ... Antiviral therapy 9 (4), 465-478, 2004 | 83 | 2004 |
| Comparison of HIV-1 genotypic resistance test interpretation systems in predicting virological outcomes over time D Frentz, CAB Boucher, M Assel, A De Luca, M Fabbiani, F Incardona, ... PloS one 5 (7), e11505, 2010 | 80 | 2010 |
| Selecting anti-HIV therapies based on a variety of genomic and clinical factors M Rosen-Zvi, A Altmann, M Prosperi, E Aharoni, H Neuvirth, ... Bioinformatics 24 (13), i399-i406, 2008 | 80 | 2008 |
| Declining prevalence of HIV-1 drug resistance in antiretroviral treatment-exposed individuals in Western Europe A De Luca, D Dunn, M Zazzi, R Camacho, C Torti, I Fanti, R Kaiser, ... The Journal of infectious diseases 207 (8), 1216-1220, 2013 | 79 | 2013 |
| Comparison of classifier fusion methods for predicting response to anti HIV-1 therapy A Altmann, M Rosen-Zvi, M Prosperi, E Aharoni, H Neuvirth, E Schülter, ... PloS one 3 (10), e3470, 2008 | 72 | 2008 |
| HIV-associated malignant lymphomas in Kenya (Equatorial Africa) S Lazzi, F Ferrari, A Nyongo, N Palummo, A De Milito, M Zazzi, L Leoncini, ... Human pathology 29 (11), 1285-1289, 1998 | 71 | 1998 |
| Human DDX3 protein is a valuable target to develop broad spectrum antiviral agents A Brai, R Fazi, C Tintori, C Zamperini, F Bugli, M Sanguinetti, E Stigliano, ... Proceedings of the National Academy of Sciences 113 (19), 5388-5393, 2016 | 70 | 2016 |
| Fatal herpesvirus 6 encephalitis after unrelated bone marrow transplant A Bosi, M Zazzi, A Amantini, M Cellerini, AM Vannucchi, A De Milito, ... Bone marrow transplantation 22 (3), 285-288, 1998 | 70 | 1998 |
| Broad nucleoside-analogue resistance implications for human immunodeficiency virus type 1 reverse-transcriptase mutations at codons 44 and 118 L Romano, G Venturi, S Bloor, R Harrigan, BA Larder, JC Major, M Zazzi The Journal of infectious diseases 185 (7), 898-904, 2002 | 69 | 2002 |
| A comparison of three computational modelling methods for the prediction of virological response to combination HIV therapy D Wang, B Larder, A Revell, J Montaner, R Harrigan, F De Wolf, J Lange, ... Artificial intelligence in medicine 47 (1), 63-74, 2009 | 68 | 2009 |
